Pular para o conteúdo
Defeito de desenvolvimento durante a embriogênese
ORPHA:93890DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Dermatológico

Uma doença causada por uma alteração na formação do embrião.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O **defeito de desenvolvimento durante a embriogênese** é uma condição decorrente de alterações que ocorrem durante a formação inicial do embrião. As alterações podem envolver a estrutura física da face, dos ossos e da pele, além de causar variações laboratoriais no líquor e no metabolismo. No Brasil, a condição não consta na lista oficial de Protocolos Clínicos e Diretrizes Terapêuticas (PCDT) do Ministério da Saúde. O atendimento aos pacientes é estruturado pela rede de serviços do SUS para o manejo dos sintomas e correção de malformações.

📋
Informacoes curadas por IA — podem conter imprecisoes

Uma doença causada por uma alteração na formação do embrião.

Em pesquisa
16 moléculas
TESTOSTERONE, TESTOSTERONE UNDECANOATE, LONAFARNIB

O que está sendo pesquisado

10 moléculas em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
TESTOSTERONETESTOSTERONE UNDECANOATELONAFARNIBMIGALASTAT HYDROCHLORIDECANAKINUMABSELUMETINIB SULFATESOMATROPINMARALIXIBAT CHLORIDE
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
3.3
France
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
761 sintomas
🧠
Neurológico
343 sintomas
😀
Face
256 sintomas
👁️
Olhos
237 sintomas
❤️
Coração
217 sintomas
💪
Músculos
211 sintomas

+ 2561 sintomas em outras categorias

Características mais comuns

—
Escroto em xale
—
Hemi-hipotrofia de membro inferior
—
Moscas volantes
—
Hérnia femoral
—
Anormalidade do sistema linfático
—
Sindactilia cutânea dos dedos 3-4 do pé
5691sintomas
Sem dados (5691)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 5691 características clínicas mais associadas, ordenadas por frequência.

Escroto em xaleShawl scrotum
Hemi-hipotrofia de membro inferiorHemihypotrophy of lower limb
Moscas volantesVitreous floaters
Hérnia femoralFemoral hernia
Anormalidade do sistema linfáticoAbnormality of the lymphatic system

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa4
Últimos 10 anos200publicações
Pico202571 papers
Linha do tempo
2022Hoje · 2026🧪 2024Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

94 genes identificados com associação a esta condição.

RREB1Ras-responsive element-binding protein 1Candidate gene tested inAltamente restrito
EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
36.9 TPM
Vagina
27.9 TPM
Skin Sun Exposed Lower leg
27.6 TPM
Tireoide
27.4 TPM
Skin Not Sun Exposed Suprapubic
27.2 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:10449UniProt:Q92766
LMNB1Lamin-B1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Initiation of Nuclear Envelope (NE) ReformationRHOF GTPase cycleRHOD GTPase cycle
MECANISMO DE DOENÇA

Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical

A slowly progressive and fatal demyelinating leukodystrophy, presenting in the fourth or fifth decade of life. Clinically characterized by early autonomic abnormalities, pyramidal and cerebellar dysfunction, and symmetric demyelination of the CNS. It differs from multiple sclerosis and other demyelinating disorders in that neuropathology shows preservation of oligodendroglia in the presence of subtotal demyelination and lack of astrogliosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
160.4 TPM
Sangue
37.7 TPM
Fibroblastos
25.6 TPM
Baço
21.1 TPM
Testículo
18.6 TPM
OUTRAS DOENÇAS (3)
microcephaly 26, primary, autosomal dominantautosomal dominant primary microcephalyadult-onset autosomal dominant demyelinating leukodystrophy
HGNC:6637UniProt:P20700
FHFumarate hydratase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Citric acid cycle (TCA cycle)Mitochondrial protein degradation
MECANISMO DE DOENÇA

Fumarase deficiency

A severe autosomal recessive metabolic disorder characterized by early-onset hypotonia, profound psychomotor retardation, and brain abnormalities, such as agenesis of the corpus callosum, gyral defects, and ventriculomegaly. Many patients show neonatal distress, metabolic acidosis, and/or encephalopathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
139.4 TPM
Fibroblastos
128.8 TPM
Coração - Ventrículo esquerdo
120.5 TPM
Músculo esquelético
115.0 TPM
Fígado
104.5 TPM
OUTRAS DOENÇAS (3)
fumaric aciduriahereditary leiomyomatosis and renal cell cancerhereditary pheochromocytoma-paraganglioma
HGNC:3700UniProt:P07954
FKBP14Peptidyl-prolyl cis-trans isomerase FKBP14Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
XBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, kyphoscoliotic type, 2

A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL2 is an autosomal recessive form characterized by severe generalized hypotonia at birth, myopathy, early-onset progressive kyphoscoliosis, joint hypermobility without contractures, hyperelastic skin with follicular hyperkeratosis, easy bruising, and occasional abnormal scarring, sensorineural hearing impairment, and normal pyridinoline excretion in urine.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
34.0 TPM
Pituitária
15.9 TPM
Cérebro - Hemisfério cerebelar
14.1 TPM
Aorta
13.2 TPM
Cervix Ectocervix
12.9 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
Ehlers-Danlos syndrome, kyphoscoliotic type, 2
HGNC:18625UniProt:Q9NWM8
VRK1Serine/threonine-protein kinase VRK1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1A

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH1A is an autosomal recessive form characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and spinal cord anterior horn cells degeneration resembling infantile spinal muscular atrophy. Additional features include muscle hypotonia, congenital contractures and respiratory insufficiency that is evident at birth.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.6 TPM
Testículo
41.3 TPM
Baço
13.9 TPM
Fibroblastos
12.9 TPM
Fallopian Tube
9.9 TPM
OUTRAS DOENÇAS (4)
neuronopathy, distal hereditary motor, autosomal recessive 10pontocerebellar hypoplasia type 1Apontocerebellar hypoplasia type 1microcephaly-complex motor and sensory axonal neuropathy syndrome
HGNC:12718UniProt:Q99986
SGSHN-sulphoglucosamine sulphohydrolaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
HS-GAG degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 3A

A severe form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life. MPS3A is characterized by earlier onset, rapid progression of symptoms and shorter survival.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
73.2 TPM
Baço
66.5 TPM
Tireoide
53.7 TPM
Pulmão
53.5 TPM
Próstata
47.9 TPM
OUTRAS DOENÇAS (1)
mucopolysaccharidosis type 3A
HGNC:10818UniProt:P51688
DISP1Protein dispatched homolog 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Holoprosencephaly 10

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE10 inheritance pattern is autosomal recessive. Autosomal dominant inheritance with incomplete penetrance or oligogenic inheritance have been reported in some families.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
17.4 TPM
Nervo tibial
16.3 TPM
Cólon sigmoide
15.6 TPM
Testículo
13.9 TPM
Esôfago - Junção
11.0 TPM
OUTRAS DOENÇAS (6)
holoprosencephaly 10alobar holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalylobar holoprosencephaly
HGNC:19711UniProt:Q96F81
MT-ND1NADH-ubiquinone oxidoreductase chain 1Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseaseMELAS syndromemitochondrial complex I deficiencymaternally-inherited Leigh syndrome
HGNC:7455UniProt:P03886
RIN2Ras and Rab interactor 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

MACS syndrome

A complex disorder of elastic tissue characterized by sagging skin and occasionally by life-threatening visceral complications.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
46.5 TPM
Cervix Ectocervix
39.5 TPM
Cervix Endocervix
37.6 TPM
Vagina
35.3 TPM
Tecido adiposo
35.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
RIN2 syndrome
HGNC:18750UniProt:Q8WYP3
EXOSC3Exosome complex component RRP40Candidate gene tested inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1B

A severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. There is diffuse muscle weakness, progressive microcephaly, global developmental delay, and brainstem involvement.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
30.1 TPM
Testículo
28.1 TPM
Fibroblastos
21.2 TPM
Cervix Endocervix
16.4 TPM
Ovário
15.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia type 1Bpontocerebellar hypoplasia type 1
HGNC:17944UniProt:Q9NQT5
SDHASuccinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Maturation of TCA enzymes and regulation of TCA cycle
MECANISMO DE DOENÇA

Mitochondrial complex II deficiency, nuclear type 1

A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. MC2DN1 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
302.0 TPM
Músculo esquelético
237.6 TPM
Coração - Átrio
206.8 TPM
Glândula adrenal
172.2 TPM
Linfócitos
168.3 TPM
OUTRAS DOENÇAS (9)
mitochondrial complex II deficiency, nuclear type 1pheochromocytoma/paraganglioma syndrome 5neurodegeneration with ataxia and late-onset optic atrophydilated cardiomyopathy 1GG
HGNC:10680UniProt:P31040
IRF6Interferon regulatory factor 6Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Interferon gamma signalingInterferon alpha/beta signaling
MECANISMO DE DOENÇA

Van der Woude syndrome 1

An autosomal dominant developmental disorder characterized by lower lip pits, cleft lip and/or cleft palate.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
188.7 TPM
Skin Sun Exposed Lower leg
170.2 TPM
Esôfago - Mucosa
122.4 TPM
Vagina
84.4 TPM
Glândula salivar
57.1 TPM
OUTRAS DOENÇAS (8)
autosomal dominant popliteal pterygium syndromevan der Woude syndrome 1van der Woude syndromecleft lip and alveolus
HGNC:6121UniProt:O14896
POLGDNA polymerase subunit gamma-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Strand-asynchronous mitochondrial DNA replication
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
48.3 TPM
Linfócitos
42.0 TPM
Baço
41.5 TPM
Útero
40.9 TPM
Pulmão
38.7 TPM
OUTRAS DOENÇAS (11)
sensory ataxic neuropathy, dysarthria, and ophthalmoparesismitochondrial DNA depletion syndrome 4bmitochondrial DNA depletion syndrome 4amitochondrial disease
HGNC:9179UniProt:P54098
ADAMTS3A disintegrin and metalloproteinase with thrombospondin motifs 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Hennekam lymphangiectasia-lymphedema syndrome 3

A form of Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymph-vessels dysplasia characterized by intestinal lymphangiectasia with severe lymphedema of the limbs, genitalia and face. In addition, affected individuals have unusual facies and some manifest intellectual disability. HKLLS3 is characterized by widespread congenital edema, facial dysmorphism and protein-losing enteropathy of variable severity. HKLLS3 transmission pattern is consistent with autosomal recessive inheritance.

OUTRAS DOENÇAS (2)
hennekam lymphangiectasia-lymphedema syndrome 3Hennekam syndrome
HGNC:219UniProt:O15072
CLP1Polyribonucleotide 5'-hydroxyl-kinase Clp1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
mRNA 3'-end processingDengue Virus-Host InteractionsProcessing of Intronless Pre-mRNAsRNA Polymerase II Transcription TerminationmRNA Polyadenylation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 10

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH10 features include cortical dysgenesis marked by a simplified gyral pattern, cortical atrophy, mild or focal cerebellar vermian volume loss, delayed myelination, progressive microcephaly, global growth and developmental delays, severe intellectual disabilities, and seizures refractory to treatment.

OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 10
HGNC:16999UniProt:Q92989
NDUFAF6NADH dehydrogenase (ubiquinone) complex I, assembly factor 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 17

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN17 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
7.9 TPM
Tireoide
7.7 TPM
Testículo
7.2 TPM
Nervo tibial
7.0 TPM
Cerebelo
6.5 TPM
OUTRAS DOENÇAS (3)
mitochondrial complex I deficiency, nuclear type 17Fanconi renotubular syndrome 5primary Fanconi syndrome
HGNC:28625UniProt:Q330K2
TAF1Transcription initiation factor TFIID subunit 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (9)
Regulation of TP53 Activity through PhosphorylationRNA Polymerase II Promoter EscapeRNA Polymerase II HIV Promoter EscapeRNA Polymerase II Pre-transcription EventsHIV Transcription Initiation
MECANISMO DE DOENÇA

Dystonia 3, torsion, X-linked

An X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. It has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
26.5 TPM
Cervix Endocervix
26.3 TPM
Ovário
25.0 TPM
Cervix Ectocervix
23.9 TPM
Fallopian Tube
23.4 TPM
OUTRAS DOENÇAS (2)
intellectual disability, X-linked, syndromic 33X-linked dystonia-parkinsonism
HGNC:11535UniProt:P21675
PURATranscriptional activator protein Pur-alphaCandidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties

An autosomal dominant disorder characterized by severe neonatal hypotonia, respiratory and feeding difficulties, encephalopathy, and severe developmental delay. Additional common features may include seizures, exaggerated startle reflex, abnormal movements, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
15.8 TPM
Cerebelo
14.9 TPM
Cérebro - Hemisfério cerebelar
14.2 TPM
Artéria tibial
13.4 TPM
Aorta
12.9 TPM
OUTRAS DOENÇAS (2)
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutationsevere neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion
HGNC:9701UniProt:Q00577
VPS33AVacuolar protein sorting-associated protein 33ACandidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
SARS-CoV-2 modulates autophagy
MECANISMO DE DOENÇA

Mucopolysaccharidosis-plus syndrome

A form of mucopolysaccharidosis, a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans, resulting in their excessive accumulation and secretion. The diseases are progressive and often display a wide spectrum of clinical severity. MPSPS is an autosomal recessive form characterized by coarse facial features, dysostosis multiplex, hepatosplenomegaly, respiratory difficulties, intellectual disability, developmental delay, pyramidal signs, severe chronic anemia, renal involvement and cardiac defects. Laboratory analyses show proteinuria with glomerular foamy cells, excess secretion of urinary glycosaminoglycans, and extremely high levels of plasma heparan sulphate. Disease onset is in infancy. Most patients die in the first years of life due to cardiorespiratory failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
25.3 TPM
Pituitária
17.0 TPM
Linfócitos
15.2 TPM
Cérebro - Hemisfério cerebelar
14.8 TPM
Fibroblastos
14.1 TPM
OUTRAS DOENÇAS (1)
mucopolysaccharidosis-plus syndrome
HGNC:18179UniProt:Q96AX1
SOS2Son of sevenless homolog 2Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (5)
G alpha (12/13) signalling eventsNRAGE signals death through JNKInterleukin-15 signalingActivation of RAC1RAC1 GTPase cycle
MECANISMO DE DOENÇA

Noonan syndrome 9

A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
25.7 TPM
Testículo
24.0 TPM
Artéria tibial
23.2 TPM
Útero
21.9 TPM
Brain Spinal cord cervical c-1
21.6 TPM
OUTRAS DOENÇAS (3)
Noonan syndrome 9RASopathyNoonan syndrome
HGNC:11188UniProt:Q07890
PDP1[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrialCandidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
Regulation of pyruvate dehydrogenase (PDH) complex
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
51.5 TPM
Glândula adrenal
34.6 TPM
Testículo
29.8 TPM
Córtex cerebral
28.2 TPM
Fibroblastos
20.0 TPM
OUTRAS DOENÇAS (1)
pyruvate dehydrogenase phosphatase deficiency
HGNC:9279UniProt:Q9P0J1
RARS2Probable arginine--tRNA ligase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 6

A disorder characterized by an abnormally small cerebellum and brainstem, infantile encephalopathy, generalized hypotonia, lethargy and poor feeding. Recurrent apnea, intractable seizures occur early in the course of this condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
47.3 TPM
Glândula adrenal
46.1 TPM
Útero
43.0 TPM
Cervix Ectocervix
42.3 TPM
Cervix Endocervix
42.1 TPM
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 6
HGNC:21406UniProt:Q5T160
PEX12Peroxisome assembly protein 12Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteinsClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 3

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
12.5 TPM
Fibroblastos
11.2 TPM
Pituitária
10.1 TPM
Glândula adrenal
9.2 TPM
Nervo tibial
9.2 TPM
OUTRAS DOENÇAS (4)
peroxisome biogenesis disorder type 3Bperoxisome biogenesis disorder 3A (Zellweger)Zellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8854UniProt:O00623
COL1A1Collagen alpha-1(I) chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Caffey disease

An autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.

OUTRAS DOENÇAS (13)
Ehlers-Danlos syndrome type 7Aosteogenesis imperfecta type 3osteogenesis imperfecta type 4osteogenesis imperfecta type 1
HGNC:2197UniProt:P02452
EXOSC8Exosome complex component RRP43Candidate gene tested inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1C

A severe autosomal recessive neurodegenerative disease characterized by cerebellar and corpus callosum hypoplasia, abnormal myelination of the central nervous system, and spinal motor neuron disease. Affected individuals manifest failure to thrive, severe muscle weakness, spasticity and psychomotor retardation. Vision and hearing are impaired.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.2 TPM
Testículo
43.8 TPM
Ovário
40.4 TPM
Cervix Endocervix
38.1 TPM
Fallopian Tube
37.8 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Cpontocerebellar hypoplasia type 1
HGNC:17035UniProt:Q96B26
PLXND1Plexin-D1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
NOTCH3 Intracellular Domain Regulates TranscriptionOther semaphorin interactionsRND2 GTPase cycle
MECANISMO DE DOENÇA

Congenital heart defects, multiple types, 9

An autosomal recessive disorder characterized by congenital developmental abnormalities involving structures of the heart. CHTD9 features include common arterial trunk, tetralogy of Fallot, interrupted aortic arch, right aortic arch, ventricular hypoplasia, and hypoplastic left heart, as well as other vascular and valvular anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
106.9 TPM
Tecido adiposo
104.0 TPM
Nervo tibial
94.8 TPM
Cervix Endocervix
89.0 TPM
Adipose Visceral Omentum
88.6 TPM
OUTRAS DOENÇAS (3)
congenital heart defects, multiple types, 9Mobius syndromepersistent truncus arteriosus
HGNC:9107UniProt:Q9Y4D7
MECOMHistone-lysine N-methyltransferase MECOMCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Regulation of PTEN gene transcriptionFormation of the nephric duct
EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
33.9 TPM
Rim - Medula
23.4 TPM
Pulmão
15.6 TPM
Aorta
14.7 TPM
Tecido adiposo
14.4 TPM
OUTRAS DOENÇAS (3)
radioulnar synostosis with amegakaryocytic thrombocytopenia 2radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndromeacute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)
HGNC:3498UniProt:Q03112
YY1AP1YY1-associated protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Grange syndrome

An autosomal recessive syndrome of stenosis or occlusion of multiple arteries, including renal, abdominal, cerebral and probably coronary arteries, congenital heart defects, brachydactyly, syndactyly, bone fragility, and learning disabilities.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
77.7 TPM
Cervix Ectocervix
54.7 TPM
Cérebro - Hemisfério cerebelar
54.2 TPM
Nervo tibial
53.3 TPM
Ovário
52.6 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
grange syndrome
HGNC:30935UniProt:Q9H869
MT-ATP6ATP synthase F(0) complex subunit aCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationFormation of ATP by chemiosmotic couplingCristae formationMitochondrial protein degradation
MECANISMO DE DOENÇA

Neuropathy, ataxia, and retinitis pigmentosa

A syndrome characterized by variable combination of developmental delay, psychomotor retardation, hearing loss, optic atrophy and retinitis pigmentosa, dementia, seizures, ataxia, proximal neurogenic muscle weakness, and sensory neuropathy.

OUTRAS DOENÇAS (8)
mitochondrial diseasematernally-inherited Leigh syndromefamilial infantile bilateral striatal necrosismitochondrial proton-transporting ATP synthase complex deficiency
HGNC:7414UniProt:P00846
MT-TFCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
OUTRAS DOENÇAS (4)
mitochondrial diseaseMELAS syndromeGitelman-like kidney tubulopathy due to mitochondrial DNA mutationMERRF syndrome
HGNC:7481
MRPL3Large ribosomal subunit protein uL3mCandidate gene tested inTolerante
VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationMitochondrial ribosome-associated quality controlMitochondrial translation initiationMitochondrial translation elongation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 9

A mitochondrial disease characterized by failure to thrive, poor feeding, hypertrophic cardiomyopathy, hepatomegaly, and psychomotor retardation. Death in infancy has been observed in some cases.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
147.1 TPM
Fibroblastos
142.8 TPM
Testículo
72.3 TPM
Tireoide
70.7 TPM
Ovário
69.2 TPM
OUTRAS DOENÇAS (1)
combined oxidative phosphorylation defect type 9
HGNC:10379UniProt:P09001
BRAFSerine/threonine-protein kinase B-rafDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Spry regulation of FGF signalingParadoxical activation of RAF signaling by kinase inactive BRAFARMS-mediated activationSignalling to p38 via RIT and RIN
OUTRAS DOENÇAS (18)
Noonan syndrome 7LEOPARD syndrome 3melanoma, cutaneous malignant, susceptibility to, 1lung cancer
HGNC:1097UniProt:P15056
ERAL1GTPase Era, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationMitochondrial ribosome-associated quality controlMitochondrial translation initiationMitochondrial translation elongation
MECANISMO DE DOENÇA

Perrault syndrome 6

A form of Perrault syndrome, a sex-influenced disorder characterized by sensorineural deafness in both males and females, and ovarian dysgenesis in females. Affected females have primary amenorrhea, streak gonads, and infertility, whereas affected males show normal pubertal development and are fertile. PRLTS6 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
88.6 TPM
Cerebelo
84.5 TPM
Linfócitos
71.5 TPM
Fibroblastos
68.2 TPM
Útero
63.8 TPM
OUTRAS DOENÇAS (3)
Perrault syndrome 6Perrault syndrome 1Perrault syndrome 2
HGNC:3424UniProt:O75616
AUTS2Autism susceptibility gene 2 proteinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 26

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD26 features include autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms.

OUTRAS DOENÇAS (2)
autism spectrum disorder due to AUTS2 deficiencyB-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2)
HGNC:14262UniProt:Q8WXX7
WASHC5WASH complex subunit 5Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 8, autosomal dominant

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
59.7 TPM
Artéria tibial
29.9 TPM
Útero
29.4 TPM
Tecido adiposo
28.6 TPM
Linfócitos
28.2 TPM
OUTRAS DOENÇAS (3)
Ritscher-Schinzel syndrome 1hereditary spastic paraplegia 8Ritscher-Schinzel syndrome
HGNC:28984UniProt:Q12768
SATB1DNA-binding protein SATB1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
Apoptotic cleavage of cellular proteinsSUMOylation of chromatin organization proteins
MECANISMO DE DOENÇA

Den Hoed-de Boer-Voisin syndrome

A disorder characterized by global developmental delay, moderately to severely impaired intellectual development, poor or absent speech, delayed motor skills, and early-onset epilepsy in many patients. Most affected individuals have feeding difficulties, poor overall growth, dysmorphic facial features, and significant dental anomalies resembling amelogenesis imperfecta. More variable features include visual defects, behavioral abnormalities, and non-specific involvement of other organ systems. DHDBV transmission pattern is consistent with autosomal dominant inheritance with incomplete penetrance and variable expressivity.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
28.5 TPM
Bladder
28.2 TPM
Cólon sigmoide
26.4 TPM
Artéria tibial
24.2 TPM
Tireoide
20.6 TPM
OUTRAS DOENÇAS (3)
Kohlschutter-Tonz syndrome-likedevelopmental delay with dysmorphic facies and dental anomaliesintellectual disability-epilepsy-dental anomalies-facial dysmorphism syndrome
HGNC:10541UniProt:Q01826
GNAS-AS1Disease-causing germline mutation(s) inDesconhecido
VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
OUTRAS DOENÇAS (1)
pseudohypoparathyroidism type 1B
HGNC:HGNC:24872
SPECC1LCytospin-ACandidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Facial clefting, oblique, 1

A rare form of facial clefting. A facial cleft is any of the fissures between the embryonic prominences that normally unite to form the face.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.8 TPM
Esôfago - Muscular
43.6 TPM
Artéria tibial
43.1 TPM
Cérebro - Hemisfério cerebelar
41.4 TPM
Útero
41.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (3)
Tessier number 4 facial cleftTeebi hypertelorism syndrome 1commissural facial cleft
HGNC:29022UniProt:Q69YQ0
QRSL1Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrialCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 40

An autosomal recessive mitochondrial disorder characterized by prenatal or infantile onset, fetal hydrops, severe hypertrophic cardiomyopathy, poor growth, sensorineural hearing loss, hepatic dysfunction, lactic acidosis, and decreased activities of mitochondrial respiratory complexes I, III, IV, and V. The disorder is lethal, with death occurring in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
17.2 TPM
Baço
12.2 TPM
Nervo tibial
10.9 TPM
Músculo esquelético
10.6 TPM
Fibroblastos
10.5 TPM
OUTRAS DOENÇAS (1)
combined oxidative phosphorylation deficiency 40
HGNC:21020UniProt:Q9H0R6
MT-THCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (1)
Catecholamine biosynthesis
OUTRAS DOENÇAS (4)
mitochondrial diseaseMERRF syndromeMELAS syndromemitochondrial non-syndromic sensorineural hearing loss
HGNC:7487
GUSBBeta-glucuronidaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
CS/DS degradationHyaluronan degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 7

A form of mucopolysaccharidosis, a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans, resulting in their excessive accumulation and secretion. The diseases are progressive and often display a wide spectrum of clinical severity. MPS7 is an autosomal recessive form with a highly variable phenotype, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
87.0 TPM
Pulmão
72.5 TPM
Tireoide
72.5 TPM
Nervo tibial
69.4 TPM
Ovário
67.2 TPM
OUTRAS DOENÇAS (1)
mucopolysaccharidosis type 7
HGNC:4696UniProt:P08236
SLC12A2Solute carrier family 12 member 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cation-coupled Chloride cotransporters
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 78

A form of non-syndromic deafness characterized by congenital, profound bilateral sensorineural hearing loss affecting all frequencies. Some patients may have mild motor delay early in life due to vestibular dysfunction. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
46.6 TPM
Glândula salivar
43.8 TPM
Brain Spinal cord cervical c-1
38.2 TPM
Intestino delgado
28.1 TPM
Esôfago - Muscular
27.6 TPM
OUTRAS DOENÇAS (3)
Kilquist syndromeDelpire-McNeill syndromehearing loss, autosomal dominant 78
HGNC:10911UniProt:P55011
POLR3BDNA-directed RNA polymerase III subunit RPC2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Cytosolic sensors of pathogen-associated DNA
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism

An autosomal recessive neurodegenerative disorder characterized by early childhood onset of cerebellar ataxia and mild intellectual disabilities associated with diffuse hypomyelination apparent on brain MRI. Variable features include oligodontia and/or hypogonadotropic hypogonadism.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.8 TPM
Skin Sun Exposed Lower leg
9.5 TPM
Esôfago - Mucosa
8.9 TPM
Skin Not Sun Exposed Suprapubic
8.5 TPM
Vagina
8.0 TPM
OUTRAS DOENÇAS (3)
hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadismCharcot-Marie-Tooth disease, demyelinating, IIA 1Iobsolete hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome
HGNC:30348UniProt:Q9NW08
NDUFA8NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 37

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN37 features include developmental delay, cerebral atrophy, epilepsy, growth retardation, congenital myopathy with disproportion of fibers, and severely decreased activity of complex I. MC1DN37 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
220.3 TPM
Coração - Átrio
208.0 TPM
Testículo
204.3 TPM
Brain Frontal Cortex BA9
172.0 TPM
Cólon sigmoide
162.4 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 37
HGNC:HGNC:7692UniProt:P51970
MVKMevalonate kinaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Mevalonic aciduria

Accumulation of mevalonic acid which causes a variety of symptoms such as psychomotor retardation, dysmorphic features, cataracts, hepatosplenomegaly, lymphadenopathy, anemia, hypotonia, myopathy, and ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
41.6 TPM
Esôfago - Mucosa
40.7 TPM
Skin Sun Exposed Lower leg
34.1 TPM
Rim - Medula
33.4 TPM
Skin Not Sun Exposed Suprapubic
32.7 TPM
OUTRAS DOENÇAS (5)
mevalonic aciduriaporokeratosis 3, disseminated superficial actinic typehyperimmunoglobulinemia D with periodic feverporokeratosis of Mibelli
HGNC:7530UniProt:Q03426
CHMP1ACharged multivesicular body protein 1aDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
HCMV Late Events
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 8

An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
pontocerebellar hypoplasia type 8
HGNC:8740UniProt:Q9HD42
COL1A2Collagen alpha-2(I) chainCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAssembly of collagen fibrils and other multimeric structuresECM proteoglycansFibronectin matrix formation
MECANISMO DE DOENÇA

Ehlers-Danlos syndrome, arthrochalasia type, 2

A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH2 is an autosomal dominant condition characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement.

OUTRAS DOENÇAS (11)
combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Ehlers-Danlos syndrome, arthrochalasia type, 2osteogenesis imperfecta type 2osteogenesis imperfecta type 4
HGNC:2198UniProt:P08123
SUMF1Formylglycine-generating enzymeDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
The activation of arylsulfatasesGlycosphingolipid catabolism
MECANISMO DE DOENÇA

Multiple sulfatase deficiency

A clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
20.9 TPM
Aorta
17.9 TPM
Tireoide
16.0 TPM
Artéria coronária
14.4 TPM
Esôfago - Mucosa
13.6 TPM
OUTRAS DOENÇAS (1)
mucosulfatidosis
HGNC:20376UniProt:Q8NBK3
IDSIduronate 2-sulfataseCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
MPS II - Hunter syndrome (CS/DS degradation)MPS II - Hunter syndrome (HS-GAG degradation)
MECANISMO DE DOENÇA

Mucopolysaccharidosis 2

An X-linked lysosomal storage disease characterized by intracellular accumulation of heparan sulfate and dermatan sulfate and their excretion in urine. Most children with MPS2 have a severe form with early somatic abnormalities including skeletal deformities, hepatosplenomegaly, and progressive cardiopulmonary deterioration. A prominent feature is neurological damage that presents as developmental delay and hyperactivity but progresses to intellectual disability and dementia. They die before 15 years of age, usually as a result of obstructive airway disease or cardiac failure. In contrast, those with a mild form of MPS2 may survive into adulthood, with attenuated somatic complications and often without intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Anterior cingulate cortex BA24
427.4 TPM
Brain Frontal Cortex BA9
413.8 TPM
Córtex cerebral
282.6 TPM
Brain Nucleus accumbens basal ganglia
262.1 TPM
Cérebro - Amígdala
242.7 TPM
OUTRAS DOENÇAS (3)
mucopolysaccharidosis type 2mucopolysaccharidosis type 2, severe formmucopolysaccharidosis type 2, attenuated form
HGNC:5389UniProt:P22304
LRP2Low-density lipoprotein receptor-related protein 2Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (5)
Transport of RCbl within the bodyVitamin D (calciferol) metabolismClathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosisRetinoid metabolism and transport
MECANISMO DE DOENÇA

Donnai-Barrow syndrome

An autosomal recessive syndrome characterized by complete or partial agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphology, ocular anomalies, sensorineural hearing loss, developmental delay, and proteinuria. There is variability in the expression of some features, such as diaphragmatic hernia, corpus callosum anomalies and proteinuria.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
27.4 TPM
Rim - Córtex
20.7 TPM
Brain Spinal cord cervical c-1
14.1 TPM
Rim - Medula
7.8 TPM
Substância negra
4.7 TPM
OUTRAS DOENÇAS (1)
Donnai-Barrow syndrome
HGNC:6694UniProt:P98164
CTCFTranscriptional repressor CTCFDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Activation of anterior HOX genes in hindbrain development during early embryogenesis
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 21

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
53.0 TPM
Cérebro - Hemisfério cerebelar
51.4 TPM
Útero
49.2 TPM
Cervix Ectocervix
48.2 TPM
Cervix Endocervix
48.0 TPM
OUTRAS DOENÇAS (1)
intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome
HGNC:13723UniProt:P49711
PIGTGPI-anchor transamidase component PIGTDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Attachment of GPI anchor to uPAR
MECANISMO DE DOENÇA

Multiple congenital anomalies-hypotonia-seizures syndrome 3

An autosomal recessive syndrome characterized by distinct facial features, intellectual disability, hypotonia and seizures, in combination with abnormal skeletal, endocrine, and ophthalmologic findings including impaired vision, as well as abnormal motility of the eyes.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
53.6 TPM
Artéria coronária
42.9 TPM
Artéria tibial
38.8 TPM
Útero
35.9 TPM
Fibroblastos
35.5 TPM
OUTRAS DOENÇAS (2)
multiple congenital anomalies-hypotonia-seizures syndrome 3paroxysmal nocturnal hemoglobinuria 2
HGNC:14938UniProt:Q969N2
MRM2rRNA methyltransferase 2, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
rRNA modification in the mitochondrion
MECANISMO DE DOENÇA

Mitochondrial DNA depletion syndrome 17

An autosomal recessive mitochondrial disorder characterized by childhood onset of rapidly progressive encephalopathy, stroke-like episodes, lactic acidosis, hypocitrullinemia, multiple defects of oxidative phosphorylation, mitochondrial complex I and IV deficiency, and reduced mtDNA copy number.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
49.9 TPM
Fibroblastos
31.2 TPM
Baço
22.1 TPM
Útero
20.5 TPM
Testículo
20.4 TPM
OUTRAS DOENÇAS (1)
mitochondrial DNA depletion syndrome 17
HGNC:HGNC:16352UniProt:Q9UI43
EXOSC9Exosome complex component RRP45Candidate gene tested inTolerante
VIAS BIOLÓGICAS (5)
mRNA decay by 3' to 5' exoribonucleaseATF4 activates genes in response to endoplasmic reticulum stressKSRP (KHSRP) binds and destabilizes mRNAButyrate Response Factor 1 (BRF1) binds and destabilizes mRNATristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 1D

An autosomal recessive neurologic disorder with onset at birth or in infancy, and characterized by progressive axonal motor neuronopathy, severe generalized hypotonia, respiratory insufficiency, and cerebellar atrophy. Death in childhood may occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
43.9 TPM
Testículo
34.6 TPM
Fibroblastos
34.4 TPM
Nervo tibial
24.9 TPM
Cérebro - Hemisfério cerebelar
23.4 TPM
OUTRAS DOENÇAS (2)
pontocerebellar hypoplasia, type 1Dpontocerebellar hypoplasia type 1
HGNC:9137UniProt:Q06265
PEX1Peroxisomal ATPase PEX1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 1

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
23.8 TPM
Nervo tibial
23.3 TPM
Cervix Endocervix
23.1 TPM
Tireoide
21.9 TPM
Cerebelo
21.8 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 1Bperoxisome biogenesis disorder 1A (Zellweger)peroxisome biogenesis disorder due to PEX1 defectZellweger spectrum disorders
HGNC:8850UniProt:O43933
UBBPolyubiquitin-BCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of active ubiquitin: roles of E1 and E2 enzymes
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
592.0 TPM
Linfócitos
427.6 TPM
Sangue
426.1 TPM
Brain Spinal cord cervical c-1
409.3 TPM
Pituitária
406.5 TPM
OUTRAS DOENÇAS (4)
submucosal cleft palatecleft soft palatebifid uvulacleft hard palate
HGNC:12463UniProt:P0CG47
ARVCFSplicing regulator ARVCFCandidate gene tested inTolerante
OUTRAS DOENÇAS (1)
22q11.2 deletion syndrome
HGNC:728UniProt:O00192
COX10Protoheme IX farnesyltransferase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 3

An autosomal recessive mitochondrial disorder characterized by cytochrome c oxidase deficiency. Clinical features include muscle weakness, hypotonia, ataxia, ptosis, metabolic acidosis, poor feeding, delayed motor development, anemia, sensorineural hearing loss, and cardiomyopathy.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 3mitochondrial complex IV deficiency, nuclear-type
HGNC:2260UniProt:Q12887
SURF1Surfeit locus protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 1

An autosomal recessive disorder of the mitochondrial respiratory chain characterized by early-onset, rapidly progressive encephalopathy, neurodegeneration, and loss of motor and cognitive skills. Affected individuals show hypotonia, failure to thrive, loss of the ability to sit or walk, poor communication, poor eye contact, oculomotor abnormalities, as well as deafness, ataxia, tremor, and brisk tendon reflexes. Brain imaging shows bilateral symmetric lesions in the basal ganglia. Lactate levels in serum and cerebrospinal fluid are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV. Death in childhood may occur, often due to central respiratory failure.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
67.2 TPM
Artéria tibial
65.0 TPM
Aorta
63.9 TPM
Cólon sigmoide
62.4 TPM
Esôfago - Junção
60.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 1Charcot-Marie-Tooth disease type 4K
HGNC:11474UniProt:Q15526
PTCH2Protein patched homolog 2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Class B/2 (Secretin family receptors)
MECANISMO DE DOENÇA

Medulloblastoma

Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
50.1 TPM
Ovário
41.7 TPM
Nervo tibial
32.2 TPM
Cerebelo
23.6 TPM
Cérebro - Hemisfério cerebelar
20.7 TPM
OUTRAS DOENÇAS (4)
medulloblastomabasal cell carcinoma, susceptibility to, 1commissural facial cleftnevoid basal cell carcinoma syndrome
HGNC:9586UniProt:Q9Y6C5
PEX16Peroxisomal membrane protein PEX16Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Class I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 9

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
31.4 TPM
Testículo
30.9 TPM
Tireoide
24.5 TPM
Nervo tibial
23.1 TPM
Brain Spinal cord cervical c-1
22.4 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 8A (Zellweger)peroxisome biogenesis disorder 8BZellweger spectrum disordersobsolete neonatal adrenoleukodystrophy
HGNC:8857UniProt:Q9Y5Y5
CEP41Centrosomal protein of 41 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 15

An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly.

OUTRAS DOENÇAS (3)
Joubert syndrome 15Joubert syndromeJoubert syndrome with ocular defect
HGNC:12370UniProt:Q9BYV8
CDT1DNA replication factor Cdt1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
Activation of the pre-replicative complexOrc1 removal from chromatinSwitching of origins to a post-replicative stateAssembly of the pre-replicative complexG1/S-Specific Transcription
MECANISMO DE DOENÇA

Meier-Gorlin syndrome 4

A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal.

OUTRAS DOENÇAS (2)
Meier-Gorlin syndrome 4Meier-Gorlin syndrome
HGNC:24576UniProt:Q9H211
LBRDelta(14)-sterol reductase LBRDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
Initiation of Nuclear Envelope (NE) ReformationCholesterol biosynthesis via desmosterol (Bloch pathway)Regulation of MECP2 expression and activity
MECANISMO DE DOENÇA

Pelger-Huet anomaly

An autosomal dominant inherited abnormality of granulocytes, characterized by abnormal ovoid shape, reduced nuclear segmentation and an apparently looser chromatin structure.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
89.3 TPM
Linfócitos
88.9 TPM
Útero
68.5 TPM
Esôfago - Muscular
63.1 TPM
Cervix Ectocervix
54.0 TPM
OUTRAS DOENÇAS (4)
Greenberg dysplasiaregressive spondylometaphyseal dysplasiaPelger-Huet anomalyReynolds syndrome
HGNC:6518UniProt:Q14739
AFG3L2Mitochondrial inner membrane m-AAA protease component AFG3L2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Processing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 28

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA28 is an autosomal dominant cerebellar ataxia (ADCA) with a slow progressive course and no evidence of sensory involvement or cognitive impairment.

OUTRAS DOENÇAS (3)
optic atrophy 12spinocerebellar ataxia type 28spastic ataxia 5
HGNC:315UniProt:Q9Y4W6
DLATDihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
PDH complex synthesizes acetyl-CoA from PYRProtein lipoylationRegulation of pyruvate dehydrogenase (PDH) complex
EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
38.4 TPM
Linfócitos
37.6 TPM
Coração - Ventrículo esquerdo
36.5 TPM
Fibroblastos
31.1 TPM
Coração - Átrio
26.7 TPM
OUTRAS DOENÇAS (1)
pyruvate dehydrogenase E2 deficiency
HGNC:2896UniProt:P10515
MTX2Metaxin-2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Mitochondrial protein importCristae formation
MECANISMO DE DOENÇA

Mandibuloacral dysplasia progeroid syndrome

A form of mandibuloacral dysplasia, a rare progeroid disorder with clinical and genetic heterogeneity, characterized by growth retardation, craniofacial dysmorphic features due to distal bone resorption, musculoskeletal and skin abnormalities associated with lipodystrophy. MDPS is an autosomal recessive disorder. Clinical features include poor growth, osteoporosis, osteopenia, acroosteolysis of distal phalanges, arterial calcification, renal glomerulosclerosis and severe hypertension.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
81.7 TPM
Linfócitos
65.9 TPM
Fibroblastos
54.7 TPM
Brain Frontal Cortex BA9
53.5 TPM
Brain Spinal cord cervical c-1
48.4 TPM
OUTRAS DOENÇAS (1)
mandibuloacral dysplasia progeroid syndrome
HGNC:7506UniProt:O75431
TSEN54tRNA-splicing endonuclease subunit Sen54Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
tRNA processing in the nucleus
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 4

A disorder characterized by an abnormally small cerebellum and brainstem, severe neonatal encephalopathy, microcephaly, myoclonus and muscular hypertonia. There is a severe inferior olivary and pontine neuronal loss and a diffuse white matter gliosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
61.6 TPM
Cérebro - Hemisfério cerebelar
59.4 TPM
Baço
34.8 TPM
Tireoide
34.5 TPM
Próstata
33.2 TPM
OUTRAS DOENÇAS (4)
pontocerebellar hypoplasia type 4pontocerebellar hypoplasia type 2Apontocerebellar hypoplasia type 5pontocerebellar hypoplasia type 2
HGNC:27561UniProt:Q7Z6J9
MT-TL1Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (3)
G alpha (i) signalling eventsFormyl peptide receptors bind formyl peptides and many other ligandsG alpha (q) signalling events
OUTRAS DOENÇAS (7)
mitochondrial diseasematernally-inherited Leigh syndromeMELAS syndromeMERRF syndrome
HGNC:7490
POLG2DNA polymerase subunit gamma-2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Strand-asynchronous mitochondrial DNA replicationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
30.1 TPM
Ovário
22.2 TPM
Linfócitos
19.3 TPM
Cervix Endocervix
18.3 TPM
Útero
16.6 TPM
OUTRAS DOENÇAS (4)
progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4mitochondrial DNA depletion syndrome 16 (hepatic type)mitochondrial dna depletion syndrome 16B (neuroophthalmic type)autosomal dominant progressive external ophthalmoplegia
HGNC:9180UniProt:Q9UHN1
LAMA1Laminin subunit alpha-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (8)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactionsNon-integrin membrane-ECM interactions
MECANISMO DE DOENÇA

Poretti-Boltshauser syndrome

An autosomal recessive disorder characterized by cerebellar dysplasia, cerebellar vermis atrophy, cerebellar cysts in most patients, high myopia, variable retinal dystrophy, and eye movement abnormalities including strabismus, ocular apraxia, nystagmus. Affected individuals have ataxia, delayed motor development, language impairment, and intellectual disability with variable severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
22.3 TPM
Fibroblastos
17.2 TPM
Rim - Medula
6.8 TPM
Tireoide
6.6 TPM
Ovário
4.1 TPM
OUTRAS DOENÇAS (1)
ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
HGNC:6481UniProt:P25391
COX6B1Cytochrome c oxidase subunit 6B1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 7

An autosomal recessive mitochondrial disorder characterized by encephalomyopathy resulting in variable clinical manifestations. Features include muscle weakness, gait disturbances, neurodegeneration, cognitive decline, metabolic acidosis, feeding difficulties, poor overall growth, cortical visual impairment, and hypertrophic cardiomyopathy. Serum lactate levels are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 7mitochondrial complex IV deficiency, nuclear-type
HGNC:2280UniProt:P14854
HGSNATHeparan-alpha-glucosaminide N-acetyltransferaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
HS-GAG degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 3C

A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
80.4 TPM
Cervix Ectocervix
76.1 TPM
Ovário
71.9 TPM
Nervo tibial
67.3 TPM
Útero
66.7 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (3)
mucopolysaccharidosis type 3Cretinitis pigmentosa 73retinitis pigmentosa
HGNC:26527UniProt:Q68CP4
MT-ND4NADH-ubiquinone oxidoreductase chain 4Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (6)
mitochondrial diseasematernally-inherited Leigh syndromeMELAS syndromeLeber plus disease
HGNC:7459UniProt:P03905
VPS35LVPS35 endosomal protein-sorting factor-likeDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Ritscher-Schinzel syndrome 3

A form of Ritscher-Schinzel syndrome, a developmental malformation syndrome characterized by cerebellar brain malformations, congenital heart defects, and craniofacial abnormalities. RTSC3 is an autosomal recessive form. Affected individuals show cranio-cerebello-cardiac anomalies, coloboma, microphthalmia, chondrodysplasia punctata, complicated skeletal malformations, periventricular nodular heterotopia and proteinuria.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
Ritscher-Schinzel syndrome 3Ritscher-Schinzel syndrome
HGNC:24641UniProt:Q7Z3J2
CNTNAP2Contactin-associated protein-like 2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Autism 15

A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate intellectual disability.

OUTRAS DOENÇAS (2)
cortical dysplasia-focal epilepsy syndromeautism, susceptibility to, 15
HGNC:13830UniProt:Q9UHC6
B4GALT1Beta-1,4-galactosyltransferase 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (4)
Pre-NOTCH Processing in GolgiKeratan sulfate biosynthesisN-Glycan antennae elongationLactose synthesis
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 2D

A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

OUTRAS DOENÇAS (2)
combined low LDL and fibrinogenB4GALT1-congenital disorder of glycosylation
HGNC:924UniProt:P15291
SLC25A4ADP/ATP translocase 1Disease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 2

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
563.9 TPM
Coração - Átrio
428.0 TPM
Músculo esquelético
370.5 TPM
Cérebro - Hemisfério cerebelar
138.9 TPM
Esôfago - Muscular
110.1 TPM
OUTRAS DOENÇAS (5)
mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessivemitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominantprogressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2autosomal dominant progressive external ophthalmoplegia
HGNC:10990UniProt:P12235
OPHN1Oligophrenin-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
RAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOB GTPase cycleRAC1 GTPase cycle
MECANISMO DE DOENÇA

Intellectual developmental disorder, X-linked, syndromic, Billuart type

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSBL patients manifest intellectual disability associated with cerebellar hypoplasia and distinctive facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
17.3 TPM
Cervix Endocervix
16.2 TPM
Nervo tibial
15.6 TPM
Brain Nucleus accumbens basal ganglia
10.0 TPM
Próstata
9.6 TPM
OUTRAS DOENÇAS (1)
X-linked intellectual disability-cerebellar hypoplasia syndrome
HGNC:8148UniProt:O60890
COL11A1Collagen alpha-1(XI) chainDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Stickler syndrome 2

An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable.

OUTRAS DOENÇAS (8)
Marshall syndromeStickler syndrome type 2hearing loss, autosomal dominant 37fibrochondrogenesis 1
HGNC:2186UniProt:P12107
NDUFS2NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 6

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN6 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
154.5 TPM
Ovário
130.0 TPM
Cérebro - Hemisfério cerebelar
124.7 TPM
Coração - Ventrículo esquerdo
120.8 TPM
Cerebelo
120.6 TPM
OUTRAS DOENÇAS (4)
mitochondrial complex I deficiency, nuclear type 6Leber-like hereditary optic neuropathy, autosomal recessive 2mitochondrial complex I deficiencyLeber hereditary optic neuropathy
HGNC:7708UniProt:O75306
GNASProtein ALEXCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
1324.4 TPM
Tireoide
727.3 TPM
Hipotálamo
548.6 TPM
Brain Frontal Cortex BA9
501.2 TPM
Cérebro - Hemisfério cerebelar
474.1 TPM
OUTRAS DOENÇAS (12)
progressive osseous heteroplasiapituitary adenoma 3, multiple typespseudohypoparathyroidism type 1CMcCune-Albright syndrome
HGNC:4392UniProt:P84996
MYH3Myosin-3Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Arthrogryposis, distal, 2A

A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA2A is characterized by contractures of the hands and feet, oropharyngeal abnormalities, scoliosis, and a distinctive face that includes a very small oral orifice, puckered lips, and a H-shaped dimple of the chin.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
17.2 TPM
Próstata
9.7 TPM
Cervix Ectocervix
9.2 TPM
Tireoide
8.6 TPM
Cervix Endocervix
8.5 TPM
OUTRAS DOENÇAS (8)
contractures, pterygia, and variable skeletal fusions syndrome 1Bcontractures, pterygia, and spondylocarpotarsal fusion syndrome 1Aarthrogryposis, distal, type 2B3Freeman-Sheldon syndrome
HGNC:7573UniProt:P11055
DGUOKDeoxyguanosine kinase, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Purine salvage
MECANISMO DE DOENÇA

Mitochondrial DNA depletion syndrome 3

A disorder due to mitochondrial dysfunction characterized by onset in infancy of progressive liver failure, hypoglycemia, increased lactate in body fluids, and neurologic abnormalities including hypotonia, encephalopathy, peripheral neuropathy. Affected tissues show both decreased activity of the mtDNA-encoded respiratory chain complexes and mtDNA depletion.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
78.1 TPM
Pituitária
72.5 TPM
Ovário
63.9 TPM
Aorta
61.4 TPM
Testículo
61.4 TPM
OUTRAS DOENÇAS (3)
mitochondrial DNA depletion syndrome 3 (hepatocerebral type)portal hypertension, noncirrhotic, 1progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4
HGNC:2858UniProt:Q16854
PPP2R5DSerine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoformCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Houge-Janssens syndrome 1

An autosomal dominant disorder characterized by global developmental delay, hypotonia, variably impaired intellectual development, poor speech, and dysmorphic facial features. Additional more variable features may include macrocephaly and seizures.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
102.8 TPM
Cérebro - Hemisfério cerebelar
93.0 TPM
Cervix Ectocervix
85.7 TPM
Testículo
77.0 TPM
Útero
77.0 TPM
OUTRAS DOENÇAS (1)
Hogue-Janssens syndrome 1
HGNC:9312UniProt:Q14738
SMAD4SMAD family member 4Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Transcriptional regulation of pluripotent stem cellsSMAD2/SMAD3:SMAD4 heterotrimer regulates transcriptionDownregulation of SMAD2/3:SMAD4 transcriptional activitySignaling by ActivinSignaling by NODAL
MECANISMO DE DOENÇA

Pancreatic cancer

A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
37.2 TPM
Ovário
34.9 TPM
Cervix Endocervix
34.5 TPM
Cérebro - Hemisfério cerebelar
32.5 TPM
Nervo tibial
32.3 TPM
OUTRAS DOENÇAS (7)
Myhre syndromejuvenile polyposis syndromejuvenile polyposis/hereditary hemorrhagic telangiectasia syndromefamilial pancreatic carcinoma
HGNC:6770UniProt:Q13485
ALPLAlkaline phosphatase, tissue-nonspecific isozymeCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Post-translational modification: synthesis of GPI-anchored proteins
MECANISMO DE DOENÇA

Hypophosphatasia

A metabolic bone disease characterized by defective skeletal mineralization and biochemically by deficient activity of the tissue non-specific isoenzyme of alkaline phosphatase. Four forms are distinguished, depending on the age of onset: perinatal, infantile, childhood and adult type. The perinatal form is the most severe and is almost always fatal. The adult form is mild and characterized by recurrent fractures, osteomalacia, rickets, and loss of teeth. Some cases are asymptomatic, while some patients manifest dental features without skeletal manifestations (odontohypophosphatasia).

OUTRAS DOENÇAS (5)
adult hypophosphatasiainfantile hypophosphatasiachildhood hypophosphatasiaperinatal lethal hypophosphatasia
HGNC:438UniProt:P05186
MT-TS1Candidate gene tested inDesconhecido
VIAS BIOLÓGICAS (3)
G alpha (i) signalling eventsFormyl peptide receptors bind formyl peptides and many other ligandsG alpha (q) signalling events
OUTRAS DOENÇAS (6)
mitochondrial diseaseMERRF syndromepalmoplantar keratoderma-deafness syndromematernally-inherited progressive external ophthalmoplegia
HGNC:7497
LZTR1Leucine-zipper-like transcriptional regulator 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Glioma

Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
76.5 TPM
Nervo tibial
68.8 TPM
Útero
67.8 TPM
Cervix Ectocervix
65.1 TPM
Cervix Endocervix
61.7 TPM
OUTRAS DOENÇAS (9)
Noonan syndrome 10RASopathyNoonan syndrome 2cafe au lait spots, multiple
HGNC:6742UniProt:Q8N653
PHGDHD-3-phosphoglycerate dehydrogenaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Serine metabolism
MECANISMO DE DOENÇA

Phosphoglycerate dehydrogenase deficiency

An autosomal recessive inborn error of L-serine biosynthesis, clinically characterized by congenital microcephaly, psychomotor retardation, and seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
83.1 TPM
Brain Spinal cord cervical c-1
50.3 TPM
Skin Not Sun Exposed Suprapubic
50.0 TPM
Glândula salivar
47.9 TPM
Testículo
45.6 TPM
OUTRAS DOENÇAS (2)
Neu-Laxova syndrome 1PHGDH deficiency
HGNC:8923UniProt:O43175
AARS2Alanine--tRNA ligase, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 8

A mitochondrial disease characterized by a lethal infantile hypertrophic cardiomyopathy, generalized muscle dysfunction and some neurologic involvement. The liver is not affected.

OUTRAS DOENÇAS (4)
leukoencephalopathy, progressive, with ovarian failurecombined oxidative phosphorylation defect type 8leukoencephalopathy, diffuse hereditary, with spheroids 1obsolete ovarioleukodystrophy
HGNC:21022UniProt:Q5JTZ9
IDUAAlpha-L-iduronidaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
CS/DS degradationHS-GAG degradation
MECANISMO DE DOENÇA

Mucopolysaccharidosis 1H

A severe form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1H usually present, within the first year of life, a combination of hepatosplenomegaly, skeletal deformities, corneal clouding and severe intellectual disability. Obstructive airways disease, respiratory infection and cardiac complications usually result in death before 10 years of age.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
72.3 TPM
Cérebro - Hemisfério cerebelar
53.9 TPM
Cervix Endocervix
44.9 TPM
Tireoide
37.9 TPM
Útero
37.1 TPM
OUTRAS DOENÇAS (4)
Hurler-Scheie syndromeHurler syndromeScheie syndromemucopolysaccharidosis type 1
HGNC:5391UniProt:P35475
PEX6Peroxisomal ATPase PEX6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 4

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
66.8 TPM
Ovário
64.6 TPM
Cerebelo
61.1 TPM
Cérebro - Hemisfério cerebelar
58.5 TPM
Pituitária
55.1 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 4Bperoxisome biogenesis disorder 4A (Zellweger)peroxisome biogenesis disorder due to PEX6 defectobsolete Heimler syndrome
HGNC:8859UniProt:Q13608
FAT4Protocadherin Fat 4Candidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Van Maldergem syndrome 2

An autosomal recessive disorder characterized by intellectual disability, typical craniofacial features, auditory malformations resulting in hearing loss, and skeletal and limb malformations. Some patients have renal hypoplasia. Brain MRI typically shows periventricular nodular heterotopia.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
21.5 TPM
Artéria tibial
16.6 TPM
Aorta
14.3 TPM
Artéria coronária
12.8 TPM
Cólon sigmoide
12.3 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
van Maldergem syndrome 2Hennekam lymphangiectasia-lymphedema syndrome 2Hennekam syndromevan Maldergem syndrome
HGNC:23109UniProt:Q6V0I7

Medicamentos e terapias

TESTOSTERONEPhase 4

Mecanismo: Androgen Receptor agonist

TESTOSTERONE UNDECANOATEPhase 4

Mecanismo: Androgen Receptor agonist

LONAFARNIBPhase 4

Mecanismo: Protein farnesyltransferase inhibitor

MIGALASTAT HYDROCHLORIDEPhase 4

Mecanismo: Alpha-galactosidase A stabiliser

CANAKINUMABPhase 4

Mecanismo: Interleukin-1 beta inhibitor

SELUMETINIB SULFATEPhase 4

Mecanismo: Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor

SOMATROPINPhase 4

Mecanismo: Growth hormone receptor agonist

MARALIXIBAT CHLORIDEPhase 4

Mecanismo: Ileal bile acid transporter inhibitor

METOCLOPRAMIDEPhase 3

Mecanismo: Dopamine D2 receptor antagonist

TERFENADINEPhase 3

Mecanismo: Histamine H1 receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

1.320 variantes patogênicas registradas no ClinVar.

🧬 RREB1: NM_001003699.4(RREB1):c.358T>C (p.Ser120Pro) ()
🧬 RREB1: NM_001003699.4(RREB1):c.3818C>G (p.Pro1273Arg) ()
🧬 RREB1: NM_001003699.4(RREB1):c.4222G>T (p.Glu1408Ter) ()
🧬 RREB1: NM_001003699.4(RREB1):c.4261_4281dup (p.Phe1427_Lys1428insAlaThrLysLeuMetAspPhe) ()
🧬 RREB1: NM_001003699.4(RREB1):c.3539G>A (p.Ser1180Asn) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

312 vias biológicas associadas aos genes desta condição.

Meiotic synapsis Formation of Senescence-Associated Heterochromatin Foci (SAHF) Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Breakdown of the nuclear lamina Depolymerization of the Nuclear Lamina Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation RHOD GTPase cycle RHOF GTPase cycle Citric acid cycle (TCA cycle) Mitochondrial protein degradation XBP1(S) activates chaperone genes HS-GAG degradation MPS IIIA - Sanfilippo syndrome A Mitochondrial translation termination Respiratory electron transport Complex I biogenesis RAB GEFs exchange GTP for GDP on RABs ATF4 activates genes in response to endoplasmic reticulum stress mRNA decay by 3' to 5' exoribonuclease Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA Major pathway of rRNA processing in the nucleolus and cytosol Nuclear RNA decay Maturation of TCA enzymes and regulation of TCA cycle Interferon gamma signaling Interferon alpha/beta signaling Strand-asynchronous mitochondrial DNA replication Collagen biosynthesis and modifying enzymes Defective B3GALTL causes PpS O-glycosylation of TSR domain-containing proteins tRNA processing in the nucleus mRNA 3'-end processing RNA Polymerase II Transcription Termination Processing of Intronless Pre-mRNAs mRNA Polyadenylation Dengue Virus-Host Interactions HIV Transcription Initiation RNA Polymerase II HIV Promoter Escape Transcription of the HIV genome RNA Polymerase II Pre-transcription Events Regulation of TP53 Activity through Phosphorylation RNA Polymerase II Promoter Escape RNA Polymerase II Transcription Pre-Initiation And Promoter Opening RNA Polymerase II Transcription Initiation RNA Polymerase II Transcription Initiation And Promoter Clearance SARS-CoV-2 modulates autophagy NRAGE signals death through JNK G alpha (12/13) signalling events Activation of RAC1 Interleukin-15 signaling RAC1 GTPase cycle Lanosterol biosynthesis Mitochondrial tRNA aminoacylation E3 ubiquitin ligases ubiquitinate target proteins Peroxisomal protein import Class I peroxisomal membrane protein import GPVI-mediated activation cascade Collagen degradation Fibronectin matrix formation Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Assembly of collagen fibrils and other multimeric structures Cell surface interactions at the vascular wall Integrin cell surface interactions Anchoring fibril formation Crosslinking of collagen fibrils Syndecan interactions Non-integrin membrane-ECM interactions ECM proteoglycans Scavenging by Class A Receptors GP1b-IX-V activation signalling Platelet Adhesion to exposed collagen Platelet Aggregation (Plug Formation) MET activates PTK2 signaling RUNX2 regulates osteoblast differentiation Collagen chain trimerization Enhanced cleavage of VWF variant by ADAMTS13 Enhanced binding of GP1BA variant to VWF multimer:collagen Defective VWF cleavage by ADAMTS13 variant Defective VWF binding to collagen type I Defective binding of VWF variant to GPIb:IX:V Developmental Lineage of Pancreatic Ductal Cells Other semaphorin interactions NOTCH3 Intracellular Domain Regulates Transcription RND2 GTPase cycle PKMTs methylate histone lysines Regulation of PTEN gene transcription Formation of the nephric duct Formation of ATP by chemiosmotic coupling Cristae formation Transcriptional regulation by RUNX2 NOTCH2 Activation and Transmission of Signal to the Nucleus Signaling by NOTCH2 Response of endothelial cells to shear stress Developmental Cell Lineages TP53 Regulates Transcription of Cell Death Genes SARS-CoV-2 Infection Downregulation of ERBB2 signaling Regulation of CDH1 Expression and Function Regulation of RUNX2 expression and activity Mitochondrial translation initiation Mitochondrial translation elongation Mitochondrial ribosome-associated quality control Spry regulation of FGF signaling Frs2-mediated activation ARMS-mediated activation Signalling to p38 via RIT and RIN RAF activation MAP2K and MAPK activation Negative feedback regulation of MAPK pathway Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known Apoptotic cleavage of cellular proteins SUMOylation of chromatin organization proteins GNAS GNAS1 GNAS2 GATA6-AS1 lncRNA p-2S-SMAD2,3:GATA6-AS1 lncRNA:GATA6 gene AS160:IRAP Phospho AS160:14-3-3 p-5S,T642-AS160:IRAP p-5S,T642-AS160:14-3-3:IRAP Defective MUTYH substrate processing Defective Base Excision Repair Associated with NEIL1 Signaling by MET Virion Assembly and Release Virion Assembly and Release Regulation of CDH11 Expression and Function Regulation of CDH11 gene transcription Intracellular oxygen transport IKK complex recruitment mediated by RIP1 Transcriptional regulation by RUNX1 CS/DS degradation Hyaluronan degradation MPS VII - Sly syndrome (Hyaluronan metabolism) Neutrophil degranulation MPS VII - Sly syndrome (CS/DS degradation) Cation-coupled Chloride cotransporters Cytosolic sensors of pathogen-associated DNA RNA Polymerase III Chain Elongation RNA Polymerase III Transcription Termination RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter Activation of gene expression by SREBF (SREBP) HCMV Late Events SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Interleukin-4 and Interleukin-13 signaling The activation of arylsulfatases Glycosphingolipid catabolism MPS II - Hunter syndrome (HS-GAG degradation) MPS II - Hunter syndrome (CS/DS degradation) Vitamin D (calciferol) metabolism Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Retinoid metabolism and transport Transport of RCbl within the body Activation of anterior HOX genes in hindbrain development during early embryogenesis Attachment of GPI anchor to uPAR rRNA modification in the mitochondrion Translesion synthesis by REV1 Recognition of DNA damage by PCNA-containing replication complex Translesion Synthesis by POLH Activation of NF-kappaB in B cells ISG15 antiviral mechanism Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants ER-Phagosome pathway Downregulation of ERBB4 signaling Downregulation of ERBB2:ERBB3 signaling Budding and maturation of HIV virion NOD1/2 Signaling Pathway TICAM1, RIP1-mediated IKK complex recruitment DDX58/IFIH1-mediated induction of interferon-alpha/beta APC/C:Cdc20 mediated degradation of Cyclin B Autodegradation of Cdh1 by Cdh1:APC/C SCF-beta-TrCP mediated degradation of Emi1 APC/C:Cdc20 mediated degradation of Securin APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 Cdc20:Phospho-APC/C mediated degradation of Cyclin A Membrane binding and targetting of GAG proteins Assembly Of The HIV Virion APC-Cdc20 mediated degradation of Nek2A Vpu mediated degradation of CD4 Vif-mediated degradation of APOBEC3G EGFR downregulation SCF(Skp2)-mediated degradation of p27/p21 Degradation of beta-catenin by the destruction complex TCF dependent signaling in response to WNT Heme biosynthesis Complex IV assembly Class B/2 (Secretin family receptors) Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2 Assembly of the pre-replicative complex Orc1 removal from chromatin Activation of the pre-replicative complex Switching of origins to a post-replicative state G1/S-Specific Transcription Cholesterol biosynthesis via desmosterol (Bloch pathway) RHOA GTPase cycle RHOC GTPase cycle CDC42 GTPase cycle RAC2 GTPase cycle RHOG GTPase cycle RAC3 GTPase cycle Regulation of MECP2 expression and activity Processing of SMDT1 Regulation of pyruvate dehydrogenase (PDH) complex Signaling by Retinoic Acid Protein lipoylation PDH complex synthesizes acetyl-CoA from PYR Mitochondrial protein import Mitochondrial unfolded protein response (UPRmt) NADE modulates death signalling Activation of BIM and translocation to mitochondria Activation of caspases through apoptosome-mediated cleavage Ubiquinol biosynthesis Export of Viral Ribonucleoproteins from Nucleus NEP/NS2 Interacts with the Cellular Export Machinery Transcriptional activation of mitochondrial biogenesis Laminin interactions L1CAM interactions Attachment of bacteria to epithelial cells Formation of the dystrophin-glycoprotein complex (DGC) TP53 Regulates Metabolic Genes Cytoprotection by HMOX1 MPS IIIC - Sanfilippo syndrome C Pre-NOTCH Processing in Golgi Keratan sulfate biosynthesis Interaction With Cumulus Cells And The Zona Pellucida Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) Defective B4GALT1 causes CDG-2d Lactose synthesis N-Glycan antennae elongation Mitochondrial Uncoupling Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane RHOB GTPase cycle RHOQ GTPase cycle RHOJ GTPase cycle G alpha (s):GTP:SRC dissociates G alpha (s):GTP:SRC catalyzes SRC to p-Y419-SRC G protein alpha (s):GTP binds SRC Striated Muscle Contraction Purine salvage Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal PP2A-mediated dephosphorylation of key metabolic factors DARPP-32 events Beta-catenin phosphorylation cascade ERK/MAPK targets ERKs are inactivated Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Co-stimulation by CD28 Co-inhibition by CTLA4 Platelet sensitization by LDL Disassembly of the destruction complex and recruitment of AXIN to the membrane Signaling by GSK3beta mutants CTNNB1 S33 mutants aren't phosphorylated CTNNB1 S37 mutants aren't phosphorylated CTNNB1 S45 mutants aren't phosphorylated CTNNB1 T41 mutants aren't phosphorylated APC truncation mutants have impaired AXIN binding AXIN missense mutants destabilize the destruction complex Truncations of AMER1 destabilize the destruction complex RHO GTPases Activate Formins PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Mitotic Prometaphase Regulation of glycolysis by fructose 2,6-bisphosphate metabolism EML4 and NUDC in mitotic spindle formation Signaling by NODAL Signaling by Activin Signaling by BMP TGF-beta receptor signaling activates SMADs Downregulation of SMAD2/3:SMAD4 transcriptional activity SMAD4 MH2 Domain Mutants in Cancer SMAD2/3 MH2 Domain Mutants in Cancer Transcriptional regulation of pluripotent stem cells Ub-specific processing proteases RUNX2 regulates bone development RUNX3 regulates CDKN1A transcription RUNX3 regulates BCL2L11 (BIM) transcription FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes FOXO-mediated transcription of cell cycle genes Cardiogenesis SARS-CoV-1 targets host intracellular signalling and regulatory pathways Germ layer formation at gastrulation Formation of definitive endoderm TGFBR3 expression Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 Post-translational modification: synthesis of GPI-anchored proteins Serine metabolism MPS I - Hurler syndrome (HS-GAG degradation) MPS I - Hurler syndrome (CS/DS degradation)

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado8
3Fase 32
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 1 ensaio
✓ Aprovados — podem ser usados hoje
TESTOSTERONETESTOSTERONE UNDECANOATELONAFARNIBMIGALASTAT HYDROCHLORIDECANAKINUMABSELUMETINIB SULFATESOMATROPINMARALIXIBAT CHLORIDE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Defeito de desenvolvimento durante a embriogênese

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Nenhum país com ensaio aberto no momento.

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics2026 Feb 23

Rubinstein-Taybi syndrome (RSTS) and Menke-Hennekam syndrome (MKHK) are two rare Mendelian disorders presented with variable degrees of intellectual disability and different facial dysmorphism. They are caused by loss-of-function (LOF) variants or missense/inframe deletion variants in the exon 30 and 31 of the CREBBP gene respectively. This study aimed to refine the phenotype and provide characterization of genome-wide DNA methylation (DNAm) in RSTS and MKHK. We integrated and analyzed clinical data of 151 patients with RSTS and 36 patients with MKHK from this study and literatures. Meanwhile, genome-wide DNAm analysis were carried out on 51 blood samples (RSTS n = 9, MKHK n = 8, control n = 33), and 21 human induced pluripotent cell (hiPSC) samples (RSTS n = 5, MKHK n = 4, control n = 12). Phenotype analysis showed that patients with RSTS variants downstream the last 50 nt of the penultimate exon had atypical facial malformation and severer medical problems compared to the classical RSTS caused by LOF CREBBP variants. Individuals with MKHK variants in intrinsically disordered region (IDR) showed resemblant features. Meanwhile, DNAm analysis identified two specific blood DNA methylation patterns (episignatures): RSTS and MKHK_IDR compared to matched normal controls. Samples with MKHK variants outside the IDR did not obey the MKHK_IDR episignature. By interrogating DNAm in hiPSCs of patients with RSTS and MKHK, we observed differentially methylated genes play a role in embryonic development and organogenesis. In conclusion, our results suggest that phenotypic features and DNA methylation episignatures may differ for each genomic region.

#2

Endothelin-3 and T-type Ca2+ channels drive enteric neural crest cell calcium activity, contractility and migration.

Nature communications2026 Jan 20

Enteric neural crest cells (ENCCs) colonize the gut during embryogenesis and migration defects give rise to Hirschsprung disease (HD). Mutations in GDNF/RET and EDN3/EDNRB are known to be causal in HD. Here, we show that migrating ENCCs in mice exhibit endogenous EDN3/EDNRB-gated calcium activity, mediated by chloride channels, T-type Ca2+ channels and inositol trisphosphate-sensitive intracellular-store release. We find that inhibiting Ca2+ activity results in ENCC migration defects, while exciting it promotes migration by increasing ENCC contractility and traction force to the extracellular matrix. Our study demonstrates that embryonic endothelin-mediated neural crest migration and adult endothelin-mediated vasoconstriction is one and the same phenomenon, taking place in different cell types. Our results suggest a functional link between rare mutations of CACNA1H (the gene encoding CaV3.2) and HD, and pave the way for understanding neurocristopathies in terms of neural crest cell bioelectric activity deficits.

#3

MYRF controls mesothelium specification, signaling, and plasticity in lung development.

Developmental cell2026 Mar 11

The mesothelium is a squamous monolayer that ensheathes internal organs and lines the body cavities. Aside from facilitating tissue sliding, its additional functions remain poorly understood. Here, we study the mesothelium through investigating myelin regulatory factor (Myrf), a transcription factor expressed in the mesothelium and a top mutated gene in congenital diaphragmatic hernia (CDH), a developmental disorder that affects the lung and diaphragm. In mice, inactivation of Myrf early in embryogenesis resulted in CDH and defective mesothelium specification, compromising its role as a signaling center for lung growth. Inactivation after mesothelium specification led to additional defects, including enhanced differentiation into various mesenchymal cell types, causing a striking accumulation of elastin-expressing smooth muscle/myofibroblasts encasing the lung, mimicking pleuroparenchymal fibroelastosis (PPFE), a rare adult lung condition. Compound mutants demonstrate that MYRF functions synergistically with YAP/TAZ in mesothelium differentiation. Together, these findings highlight the complex role of the mesothelium in development and disease.

#4

Unilateral absence of pulmonary artery presenting with pulmonary hypertension in two adults.

BMJ case reports2026 Jan 07

Unilateral absence of pulmonary artery (UAPA) is a rare congenital abnormality that occurs during embryonic development. Isolated UAPA has a prevalence of about 1 in 200 000. The clinical presentation varies based on age, but manifestations include recurrent pneumonia, haemoptysis, pulmonary hypertension or an incidental finding, among others. Here, we present two adult patients with isolated UAPA who were diagnosed with pulmonary hypertension and have been medically managed at our institution.

#5

The people behind the papers - Alexander Phillips and David Keays.

Development (Cambridge, England)2026 Mar 01

Certain mutations in end-binding (EB) protein 2, a member of the EB family of conserved microtubule plus-end tracking proteins, are implicated in a rare syndromic form of microcephaly. While the two other EB family members - EB1 and EB3 - have been the subject of intense study, the cellular role of EB2 is not clearly understood. In their work, Alexander (Alex) Phillips, David Keays and colleagues show that EB2 is necessary for maintaining mitotic fidelity during embryonic brain development in mouse and human. To learn more about their work, we spoke to the first author, Alex Phillips, and the corresponding author, David Keays, Adjunct Investigator at the Research Institute of Molecular Pathology (IMP), Austria, and Professor at the Ludwig-Maximilians-Universität München, Germany.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

The people behind the papers - Alexander Phillips and David Keays.

Development (Cambridge, England)
2026

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of PIK3CA mutation and a genomic landscape consistent with urothelial carcinoma.

Frontiers in oncology
2026

A Rare Case Report on Holoprosencephaly With Cyclopia: Jimma University Medical Center, Ethiopia.

Case reports in obstetrics and gynecology
2026

Correlations between phenotype and gene region-specific episignatures in Rubinstein-Taybi syndrome and Menke-Hennekam syndrome.

Human molecular genetics
2026

Lingual and Cervical Ectopic Thyroid: A Case Report and Literature Review.

Cureus
2026

Incidental finding of "H"-type duplex gallbladder: a case report.

Journal of medical case reports
2026

Endothelin-3 and T-type Ca2+ channels drive enteric neural crest cell calcium activity, contractility and migration.

Nature communications
2026

MYRF controls mesothelium specification, signaling, and plasticity in lung development.

Developmental cell
2026

Gallbladder Agenesis in a Patient With Klinefelter Syndrome Presenting With Hematemesis and Right Upper-Quadrant Pain.

The American journal of case reports
2025

Adams-Oliver Syndrome: A Comprehensive Literature Review of Clinical, Nutritional, Genetic, and Molecular Aspects with Nursing Care Considerations.

International journal of molecular sciences
2025

Whole Exome Sequencing Uncovers Genetic Syndromes Associated with Orofacial Clefts presenting with Limb abnormalities in a Sub-Saharan African cohort.

Research square
2026

Unilateral absence of pulmonary artery presenting with pulmonary hypertension in two adults.

BMJ case reports
2025

Abdominal ectopic bronchogenic cysts: a retrospective single-institution case series and literature review.

BMC surgery
2025

STARD9 and CDK5RAP2-Novel Candidate Genes for 46,XY Complete Gonadal Dysgenesis.

International journal of molecular sciences
2025

Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest.

eLife
2025

Congenital lack of penis - aphallia.

BMC pediatrics
2025

Spontaneous involution of a Rathke's cleft cyst.

BMJ case reports
2026

Genetic and embryonic transcriptome analyses reveal the molecular and developmental basis of Mayer-Rokitansky-Küster-Hauser syndrome.

Journal of medical genetics
2025

Haploinsufficiency of GRHL2 is associated with orofacial clefting in humans.

Human molecular genetics
2025

A familial case of Kallmann syndrome: novel variants in ANOS1 and GNRHR genes.

Archives of endocrinology and metabolism
2025

Molecular pathogenesis, diagnosis, and management challenges in complete androgen insensitivity syndrome.

Frontiers in endocrinology
2026

Functional Characterization of a Novel GPC3 Missense Variant in Simpson-Golabi-Behmel Syndrome.

American journal of medical genetics. Part A
2025

Clinical and molecular findings of KMT2D-related Kabuki syndrome: A series of 13 patients with 3 novel variants.

European journal of medical genetics
2025

Defective Notch1 signaling in endothelial cells drives pathogenesis in a mouse model of Adams-Oliver syndrome.

The Journal of clinical investigation
2025

Aeromedical evaluation and successful return to flight in a military pilot with lingual thyroid: a case report and follow-up.

BMC endocrine disorders
2026

A Confirmatory Case of Severe Spondylocostal Dysostosis Caused by Biallelic Loss-of-Function of DMRT2.

American journal of medical genetics. Part A
2025

Frem2 knockout mice exhibit Fraser syndrome phenotypes and neonatal lethality due to bilateral renal agenesis.

Scientific reports
2025

Craniofacial Microsomia With Tongue Cleft: Embryological Mechanisms and Clinical Implications From Three Rare Cases.

The Journal of craniofacial surgery
2025

Increased mTOR signaling secondary to a human ILK missense variant inhibits nephrogenesis with decreased metabolism.

Mechanisms of ageing and development
2025

SOX17 in pulmonary arterial hypertension: from development to clinical phenotype.

European respiratory review : an official journal of the European Respiratory Society
2025

Novel variants in ZNF462 and phenotype update in patients with Weiss-Kruszka syndrome: a case series.

Translational pediatrics
2025

Clinical and Surgical Perspectives on Isolated Thoracic Ectopia Cordis: A Rare Case Report.

Case reports in pediatrics
2025

Management of Unilateral Hearing Loss in a 14-Year-Old with Internal Auditory Canal Duplication Using a Bonebridge Bone Conduction Implant.

The American journal of case reports
2025

[Single-cell sequencing reveals the temporal expression characteristics of key molecules related to tooth agenesis and dental hard tissues in mouse molars].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
2025

Separation of Ischiopagus Conjoined Twins With Cloacal Anomaly.

Urology
2025

Diagnosis of Zinner syndrome: A case of rare occurrence.

Radiology case reports
2025

A Coffin-Siris syndrome-associated mutation modeled in Caenorhabditis elegans affects multiple developmental processes.

G3 (Bethesda, Md.)
2025

Reaching consensus as to how knowledge of development underscores our understanding of deficient ventricular septation.

Cardiology in the young
2025

Internal carotid artery agenesis: a systematic review of prevalence, basal brain circulation variations, and associated pathologies.

Anatomical science international
2025

From exencephaly to anencephaly: a catastrophic continuum of neural tube defects from embryogenesis to ultrasonographic diagnosis.

Journal of perinatal medicine
2025

Gene-environment interactions modulate the phenotype severity in mouse models of congenital craniofacial syndromes.

The Journal of clinical investigation
2025

Complicated oesophageal duplication cyst in a 55-year-old man: a rare case from Pakistan.

JPMA. The Journal of the Pakistan Medical Association
2025

Impact of Preexisting Rare Diseases on COVID-19 Severity, Reinfection, and Long COVID, and the Modifying Effects of Vaccination and Antiviral Therapy: A Retrospective Study from the N3C Data Enclave.

medRxiv : the preprint server for health sciences
2025

FBRSL1 regulates the expression of chromatin regulators BRPF1 and KAT6A.

Human genetics
2025

Adult Acute Appendicitis Complicated by Intestinal Malrotation: A Case Analysis.

The American journal of case reports
2025

Functional Annotation of De Novo Variants Found Near GWAS Loci Associated With Cleft Lip With or Without Cleft Palate.

Birth defects research
2025

Mutations in the spliceosomal gene SNW1 cause neurodevelopment disorders with microcephaly.

The Journal of clinical investigation
2025

Laparoscopic treatment of triple ureteral with ureteral calculus: A case report.

Medicine
2025

Identification of a Novel FGFR2 Gene Mutation (c.514_515delinsCT, p.Ala172Leu) in a Chinese Neonate With Apert Syndrome: A Case Report.

American journal of medical genetics. Part A
2025

Genetics Review: Joubert Syndrome.

Neonatal network : NN
2025

Fetiform teratoma: a systematic review with insights into concepts and controversies in differentiating it from fetus-in-fetu.

Pediatric surgery international
2025

Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate.

PloS one
2025

A de novo SALL4 mutation causes unilateral renal agenesis by misregulating genes involved in kidney development.

Orphanet journal of rare diseases
2025

Arhgap29 Deficiency Directly Leads to Systemic and Craniofacial Skeletal Abnormalities.

International journal of molecular sciences
2025

Congenital hypotrichosis caused by compound heterozygous variants in the LSS gene in a Chinese patient with strabismus: case report.

Frontiers in pediatrics
2025

Bilayer Electrospun Polyurethane Membrane With Tunable Elastomeric Properties for the Treatment of Congenital Diaphragmatic Hernia.

Journal of biomedical materials research. Part A
2025

Insights into Congenital Body Stalk Anomaly Coupled with Placenta Accreta Conditions: A Case Report.

The American journal of case reports
2025

[A rare placental lesion: Intraparenchymal hepatic heterotopia].

Annales de pathologie
2025

A non-syndromic orofacial cleft risk locus links tRNA splicing defects to neural crest cell pathologies.

American journal of human genetics
2025

Zinner syndrome in adult male: a rare case report.

Translational andrology and urology
2025

Partial Resection of a Tailgut Cyst Attached to the Rectum via a Transcoccygeal Approach: A Case Report With a Favorable Outcome.

Cureus
2025

Thalidomide-induced limb malformations: an update and reevaluation.

Archives of toxicology
2025

Single-cell and spatial transcriptomic analyses reveal transcriptional cell lineage heterogeneity in extracranial arteriovenous malformation.

Journal of dermatological science
2025

A Case of Bronchogenic Cyst Detected by Ultrasound.

Current medical imaging
2025

Bilateral Tessier Craniofacial Cleft Associated to Cleft Palate.

The Journal of craniofacial surgery
2025

Recessive genetic contribution to congenital heart disease in 5,424 probands.

Proceedings of the National Academy of Sciences of the United States of America
2025

De novo missense variants in the RPEL3 domain of PHACTR4 in individuals with overlapping congenital anomalies.

HGG advances
2025

Genome-coverage single-cell histone modifications for embryo lineage tracing.

Nature
2025

Management of High Urogenital Sinus in Adults: A Scoping Review.

Medicina (Kaunas, Lithuania)
2025

Reviewing the Genetic and Molecular Foundations of Congenital Spinal Deformities: Implications for Classification and Diagnosis.

Journal of clinical medicine
2025

Deciphering the digenic architecture of congenital heart disease using trio exome sequencing data.

American journal of human genetics
2025

Fetus in fetu: the importance of autopsy in uncovering hidden abnormalities.

BMJ case reports
2025

Congenital unilateral pericardial agenesis presenting as an isolated chest pain in an adolescent: a case report and comprehensive review.

Journal of cardiothoracic surgery
2025

FBXL4-Related Mitochondrial Depletion Syndrome Underscores the role of Mitophagy in Stem Cell Differentiation during Embryogenesis.

Stem cell reviews and reports
2025

Undocking of an extensive ciliary network induces proteostasis and cell fate switching resulting in severe primary ciliary dyskinesia.

Science translational medicine
2025

Sprengel deformity: What is the functional outcome of conservative treatment versus surgical correction?

Orphanet journal of rare diseases
2025

Polysplenia syndrome associated with multisystem malformation: A rare case report.

Radiology case reports
2025

Newborn with Refractory Seizures due to Hemimegalencephaly and Tuberous Sclerosis Complex: Case Report and Literature Review.

Neuropediatrics
2024

Transcriptome analysis of the aortic coarctation area.

Journal of molecular and cellular cardiology plus
2026

The elusive bipartite scaphoid: a rare congenital variant or misdiagnosed pseudoarthrosis? Proposed new radiological criteria.

Folia morphologica
2025

A review of literature of a functional, congenital intrathoracic kidney.

Journal of cardiothoracic surgery
2024

Rare STAT3 haplotypes cause a predisposition to developing congenital anomalies of the kidney and urinary tract disorder.

Turkish journal of medical sciences
2025

TFAP2E is implicated in central nervous system, orofacial and maxillofacial anomalies.

Journal of medical genetics
2025

Rare dysfunctional SCN2A variants are associated with malformation of cortical development.

Epilepsia
2024

Mirror hand and its management: a case report.

Journal of medical case reports
2024

The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes.

International journal of molecular sciences
2024

Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory.

Orphanet journal of rare diseases
2024

Homozygosity for a hypomorphic mutation in frizzled class receptor 5 causes syndromic ocular coloboma with microcornea in humans.

Human genetics
2025

Expression of Wnt signaling proteins in rare congenital bladder disorders.

Journal of pediatric urology
2024

A homozygous variant in ARHGAP39 is associated with lethal cerebellar vermis hypoplasia in a consanguineous Saudi family.

Scientific reports
2025

Rathke Cleft Cysts in Identical Twins.

World neurosurgery
2024

Toll-like receptors ligand immunomodulators for the treatment congenital diaphragmatic hernia.

Orphanet journal of rare diseases
2024

Mouse developmental defects, but not paraganglioma tumorigenesis, upon conditional Complex II loss in early Sox10+ cells.

FASEB bioAdvances
2024

A Challenging Case of Hyperfunctioning Submandibular Ectopic Thyroid Successfully Treated With 131 I.

Clinical nuclear medicine
2024

Vein of galen malformations: for patients and caregivers.

Neurosurgical review
2024

A 10-year-old female with Cor triatriatum sinister (CTS): a rare case report and literature review from Syria.

Annals of medicine and surgery (2012)
2025

Case Series of 6 Fetuses With Osteogenesis Imperfecta Type II: A Retrospective Study of Heart Pathology.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2024

Intestinal Malrotation in a Patient with Gastric Cancer during Laparoscopic Total Gastrectomy: A Case Report.

Annali italiani di chirurgia
2024

Left Ventricular Non-compaction Cardiomyopathy: A Report of a Rare Case From Saudi Arabia.

Cureus
2024

ELP1, the Gene Mutated in Familial Dysautonomia, Is Required for Normal Enteric Nervous System Development and Maintenance and for Gut Epithelium Homeostasis.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2024

Congenital absence of the gallbladder in a child: a case report.

Frontiers in pediatrics
2024

Phenotypic spectrum in Weiss-Kruszka syndrome caused by ZNF462 variants: Three new patients and literature review.

European journal of medical genetics
2024

Monosymmetros Cephalothoracopagus Tetrabrachius and Tetrapus Piglets with Syndromic Evolution.

Animals : an open access journal from MDPI
2024

1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome.

Molecular autism
2024

Supernumerary Punctum With Its Own Distinct Canaliculus.

Ophthalmic plastic and reconstructive surgery
2024

The chromatin regulator Ankrd11 controls cardiac neural crest cell-mediated outflow tract remodeling and heart function.

Nature communications
2024

A novel SALL1 C757T mutation in a Chinese family causes a rare disease --Townes-Brocks syndrome.

Italian journal of pediatrics
2024

Zinner syndrome: a radiological journey through a little known condition.

Abdominal radiology (New York)
2024

Atypical facial clefts: Tessier number 3 and 4 clefts.

Current opinion in otolaryngology &amp; head and neck surgery
2024

[Research progress of genetic research on Char syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Biallelic variants in CSMD1 are implicated in a neurodevelopmental disorder with intellectual disability and variable cortical malformations.

Cell death &amp; disease
2024

Multi-omics analysis of a case of congenital microtia reveals aldob and oxidative stress associated with microtia etiology.

Orphanet journal of rare diseases
2024

Brugada Syndrome and Pulmonary Atresia with Intact Interventricular Septum: Fortuitous Finding or New Genetic Connection?

Genes
2024

Uncommon Presentation of Xanthogranulomatous Cholecystitis in a True Gallbladder Diverticulum: A Case Report and Literature Review.

The American journal of case reports
2024

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features.

Brain : a journal of neurology
2024

The interaction of endorepellin and neurexin triggers neuroepithelial autophagy and maintains neural tube development.

Science bulletin
2024

Olfactory bulb anomalies in KBG syndrome mouse model and patients.

BMC medicine
2024

A novel NODAL variant in a young embolic stroke patient with visceral heterotaxy.

BMC neurology
2024

Caudal duplication syndrome: A rare entity.

JPMA. The Journal of the Pakistan Medical Association
2024

NODAL variants are associated with a continuum of laterality defects from simple D-transposition of the great arteries to heterotaxy.

Genome medicine
2024

Truncating variants of the sterol recognition region of SHH cause hypertelorism phenotype rather than hypotelorism-holoprosencephaly.

American journal of medical genetics. Part A
2024

The pathogenic mechanism of syndactyly type V identified in a Hoxd13Q50R knock-in mice.

Bone research
2024

p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.

International journal of biological macromolecules
2024

Mowat-Wilson Syndrome: Case Report and Review of ZEB2 Gene Variant Types, Protein Defects and Molecular Interactions.

International journal of molecular sciences
2024

Zebrafish and cellular models of SELENON-Related Myopathy exhibit novel embryonic and metabolic phenotypes.

bioRxiv : the preprint server for biology
2024

Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.

Journal of applied genetics
2024

Zebrafish as a model to investigate a biallelic gain-of-function variant in MSGN1, associated with a novel skeletal dysplasia syndrome.

Human genomics
2024

Bilateral Foramina Parietalia Permagna - A Calvarial Defect Caused by Haploinsufficiency of the Msh Homeobox 2 Gene: A Case Report and Current Literature Review.

Neuropediatrics
2024

Exploring new perspectives on congenital diaphragmatic hernia: A comprehensive review.

Biochimica et biophysica acta. Molecular basis of disease
2024

Exploring the clinical characteristics and prevalence of the annular pancreas: a meta-analysis.

HPB : the official journal of the International Hepato Pancreato Biliary Association
2024

Submucosal tunneling endoscopic fenestration with lauromacrogol ablation for an esophageal bronchogenic cyst.

Gastrointestinal endoscopy
2023

Agenesis of Dorsal Pancreas in a Young Adult: A Case Report.

JNMA; journal of the Nepal Medical Association
2024

"Strabismus in children" is not simple - bilateral persistent hyperplasia primary vitreous: a case report.

The Journal of international medical research
2024

Spontaneous Resolution of Congenital Intrahepatic Portosystemic Shunt.

Acta medica Lituanica
2024

Implication of transcription factor FOXD2 dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT).

Kidney international
2024

TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids.

Molecular psychiatry
2023

The rare malformation holoprosencephaly: pathogenesis, association with pregestational diabetes and the possible link with food pollutants.

Annali dell'Istituto superiore di sanita
2023

Multiple neural tube defects: rare developmental anomaly with an elusive embryological explanation.

BJR case reports
2024

New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant.

American journal of medical genetics. Part A
2023

FGFR1 variants contributed to families with tooth agenesis.

Human genomics
2023

Exploring the association between congenital vertebral malformations and neural tube defects.

Journal of medical genetics
2023

Novel insight into the phenotype of microcephaly 19 in the patient with missense COPB2 mutation.

European journal of medical genetics
2023

Prenatal diagnosis of lanosterol synthase deficiency: Fetal ultrasound findings as a window on family genetics.

European journal of medical genetics
2023

Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).

Stem cell reviews and reports
2023

Analyzing the factors that contribute to the development of embryological classical type of bladder exstrophy.

Anatomy &amp; cell biology
2023

Non-Neoplastic Thoracic Cysts: A Clinicopathologic Study of 136 Cases.

The American journal of surgical pathology
2023

Secondary Neurulation Defect: Terminal Myelocystocele, a Biological Leviathan.

Advances and technical standards in neurosurgery
2023

Gastrulation and Split Cord Malformation.

Advances and technical standards in neurosurgery
2023

Delayed Presentation of Malrotation: Case Series and Literature Review.

Journal of Indian Association of Pediatric Surgeons
2024

Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS-derived melanocytes.

Pigment cell &amp; melanoma research
2023

Coexistence of persistent fetal vasculature and retinoblastoma in the same eye.

Boletin medico del Hospital Infantil de Mexico
2023

Genetic Primary Microcephalies: When Centrosome Dysfunction Dictates Brain and Body Size.

Cells
2023

Dorsal pancreatic agenesis: a case report.

Annals of medicine and surgery (2012)
2024

ROR2-Related Skeletal Dysplasia Reveals Disrupted Chondrocyte Polarity through Modulation of BMP/TGF-β Signaling.

Aging and disease
2024

The azygos lobe, an incidental finding in computer tomography.

Folia morphologica
2023

Prenatal ultrasound findings, genetic testing, and literature review of Isolated left subclavian artery.

Echocardiography (Mount Kisco, N.Y.)
2023

Fourth Branchial Cleft Cyst: An Important Differential Diagnosis in Lateral Neck Masses.

Cureus
2023

The First Case Report of 47,XXY/46,XX/46,XY Mosaic Klinefelter Syndrome Patient With Mixed Connective Tissue Disorder.

American journal of men's health
2023

Use of adipose derived stem cells in Treacher Collins syndrome.

European review for medical and pharmacological sciences
2023

Developmental expression of the Sturge-Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis.

Genetics
2023

Congenital melanocytic naevus syndrome and Dandy-Walker malformation - a mistaken association: case report and literature review.

Neuroradiology
2023

Prenatal two-and three-dimensional echocardiographic diagnosis of ductal anomalous origin of the left pulmonary artery: Case report and literature review.

Echocardiography (Mount Kisco, N.Y.)
2023

Double Lumbar Localization of Myelomeningocele: Case Report.

Pediatric neurosurgery
2023

Goldenhar Syndrome: An Atypical Presentation With Developmental and Speech Delay.

Cureus
2023

Dysfunction of programmed embryo senescence is linked to genetic developmental defects.

Development (Cambridge, England)
2023

Identification of 17q12 microdeletion syndrome in a Latin American patient with maturity-onset diabetes of the young subtype 5: a case report.

Journal of medical case reports
2023

Elevated ROS levels during the early development of Angelman syndrome alter the apoptotic capacity of the developing neural precursor cells.

Molecular psychiatry
2023

Moebius Syndrome: What We Know So Far.

Cureus
2023

Rare Genetic Variants in Human APC Are Implicated in Mesiodens and Isolated Supernumerary Teeth.

International journal of molecular sciences
2023

[Upper gastrointestinal duplication complicated by perforation in a child].

Khirurgiia
2023

[Ocular alterations in patients with Alport syndrome-An update].

Die Ophthalmologie
2023

Defective Joint Development and Maintenance in GDF6-Related Multiple Synostoses Syndrome.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2023

Unilateral developmental absence of internal carotid artery with contralateral middle cerebral artery occlusion.

Surgical and radiologic anatomy : SRA
2023

Absence of Scaffold Protein Tks4 Disrupts Several Signaling Pathways in Colon Cancer Cells.

International journal of molecular sciences
2023

Prioritization of non-coding elements involved in non-syndromic cleft lip with/without cleft palate through genome-wide analysis of de novo mutations.

HGG advances
2022

Poland-Möbius syndrome: a case report implicating a novel mutation of the PLXND1 gene and literature review.

BMC pediatrics
2022

Dysregulation of the immune response in TGF-β signalopathies.

Frontiers in immunology
2022

Update on Mayer-Rokitansky-Küster-Hauser syndrome.

Frontiers of medicine
2022

gldc Is Essential for Renal Progenitor Patterning during Kidney Development.

Biomedicines
2022

[Research progress of persistent hyperplastic primary vitreous with Peters anomaly].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2022

LOF variants identifying candidate genes of laterality defects patients with congenital heart disease.

PLoS genetics
2022

A TARP Syndrome Phenotype Is Associated with a Novel Splicing Variant in RBM10.

Genes
2022

Acetate supplementation restores cognitive deficits caused by ARID1A haploinsufficiency in excitatory neurons.

EMBO molecular medicine
2023

X-linked variations in SHROOM4 are implicated in congenital anomalies of the urinary tract and the anorectal, cardiovascular and central nervous systems.

Journal of medical genetics
2022

Cervical chondrocutaneous remnant: a case report.

Archives of craniofacial surgery
2022

Clinical and Genetic Characteristics of a Cohort with Distal Vaginal Atresia.

International journal of molecular sciences
2023

Gata1s mutant mice display persistent defects in the erythroid lineage.

Blood advances
2022

Pathogenic variants in SLF2 and SMC5 cause segmented chromosomes and mosaic variegated hyperploidy.

Nature communications
2023

Genome-wide identification of disease-causing copy number variations in 450 individuals with anorectal malformations.

European journal of human genetics : EJHG
2023

Congenital Cervical Spinal Deformities.

Orthopaedics &amp; traumatology, surgery &amp; research : OTSR
2022

Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension-A Case Study Series.

Medicina (Kaunas, Lithuania)
2022

TBX6 as a cause of a combined skeletal-kidney dysplasia syndrome.

American journal of medical genetics. Part A
2022

[Surgical Treatment of the Transposition of the Great Arteries].

Kyobu geka. The Japanese journal of thoracic surgery
2022

Isolated Chorioretinal Coloboma: A Case Report.

Cureus
2022

Novel frameshift mutation in LIS1 gene is a probable cause of lissencephaly: a case report.

BMC pediatrics
2022

An isolated congenital absence of right pulmonary artery associated with pulmonary hypertension with coronary collaterals: A case report.

Echocardiography (Mount Kisco, N.Y.)
2022

A multi-disciplinary, comprehensive approach to management of children with heterotaxy.

Orphanet journal of rare diseases
2023

Hemifacial microsomia is linked to a rare homozygous variant V162I in FRK and validated in zebrafish.

Oral diseases
2022

Rare presentation of autosomal dominant polycystic kidney disease in horseshoe kidney ultrasound evaluation: a case report.

The Pan African medical journal
2022

External and internal parasitic conjoined twinning: Diverse presentation and different surgical challenges.

African journal of paediatric surgery : AJPS

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Defeito de desenvolvimento durante a embriogênese.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Defeito de desenvolvimento durante a embriogênese e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A condição decorre de falhas celulares e moleculares ocorridas na fase de formação do embrião. Diversos genes estão associados a esses defeitos, tais como *RREB1*, *LMNB1*, *FH*, *VRK1* e *IRF6*.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:93890
    Orphanet
  2. Q55788864
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Defeito de desenvolvimento durante a embriogênese. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/defeito-de-desenvolvimento-durante-a-embriogenese

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Defeito de desenvolvimento durante a embriogênese

ORPHA:93890 · MONDO:0019755
Prevalência
1-9 / 100 000
Medicamentos
16 registrados
Prevalência
3.3 (France)
MedGen
UMLS
C5680284
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara